Vlado Perkovic's Publications

About Vlado Perkovic's Publications

Board Member
  • MBBS,
  • PhD,
  • FASN,
  • FRACP

  • Glucocorticoids for IgA nephropathy-pro

    Kidney International Date published:

  • Glycemic Control and Effects of Canagliflozin in Reducing Albuminuria and eGFR

    Clinical Journal of the American Society of Nephrology Date published:

  • WCN23-0412 EFFECT OF IPTACOPAN ON PROTEINURIA AND COMPLEMENT BIOMARKERS OVER TIME IN IgA NEPHROPATHY

    Kidney International Reports Date published:

  • Effects of canagliflozin on liver steatosis and fibrosis markers in patients with type 2 diabetes and chronic kidney disease: A post hoc analysis of the CREDENCE trial

    Diabetes, Obesity and Metabolism Date published:

  • National health policies and strategies for addressing chronic kidney disease: Data from the International Society of Nephrology Global Kidney Health Atlas

    PLOS Global Public Health Date published:

  • The rationale, design and baseline data of FLOW, a kidney outcomes trial with once-weekly semaglutide in people with type 2 diabetes and chronic kidney disease

    Nephrology Dialysis Transplantation Date published:

  • A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF BION-1301 IN ADULTS WITH IGA NEPHROPATHY

    Date published:

  • HEART FAILURE IN ASCEND-ND AND ASCEND-D

    Date published:

  • LONG-TERM SAFETY OF HYPOXIA INDUCIBLE FACTOR PROLYL HYDROXYLASE INHIBITORS IN CHRONIC KIDNEY DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMISED CONTROLLED TRIALS

    Date published:

  • Daprodustat and On-Treatment Cardiovascular Events in Chronic Kidney Disease

    New England Journal of Medicine Date published:

  • Analysis of on-treatment cancer safety events with daprodustat versus conventional erythropoiesis-stimulating agents-post hoc analyses of the ASCEND-ND and ASCEND-D trials

    Nephrology Dialysis Transplantation Date published:

  • Oral Anticoagulant Use in Patients With Atrial Fibrillation and Chronic Kidney Disease: A Review of the Evidence With Recommendations for Australian Clinical Practice

    Heart, Lung and Circulation Date published:

  • Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials

    The Lancet Date published:

  • Design and population of the VALOR-CKD study: a multicenter, randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of veverimer in slowing progression of chronic kidney disease in patients with metabolic acidosis

    Nephrology Dialysis Transplantation Date published:

  • Effect of Iptacopan on Proteinuria and Complement Biomarkers Over Time in IgA Nephropathy

    Journal of the American Society of Nephrology Date published:

  • A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Sibeprenlimab Administered Subcutaneously in Patients With IgA Nephropathy

    Journal of the American Society of Nephrology Date published: